Determinants and trends of heart failure in relation to other major cardiovascular events in people with diabetes

Read full text Summarise with VIRAT
Authors: Kajal Panchal
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background: People with diabetes have an increased risk of incident heart failure (HF) compared to those without diabetes. The aetiology of HF can be categorised into two main subtypes: (i) ischaemic HF or (ii) non-ischaemic HF. Ischaemic HF is diagnosed when HF occurs in the presence of ischaemic heart disease (IHD, i.e. coronary artery disease, myocardial infarction or angina). In comparison, non-ischaemic HF is diagnosed when HF occurs in the absence of IHD. Substantial progress in cardiovascular disease prevention strategies have occurred over the past few decades. Moreover, the majority of recent evidence indicates a decline in the incidence of IHD and HF, both in the UK and internationally. However, it remains unclear whether and to what extent the incidence of ischaemic and non-ischaemic HF has changed over time in people with diabetes, as well as their subsequent risk of mortality. This is important to aid the development of more tailored HF prevention and management strategies by potentially accounting for HF aetiology and diabetes status.Methods: First, I conducted a systematic review and meta-analysis to investigate the association between diabetes and incident HF in people with and without prevalent cardiovascular disease. Then, I used Poisson regression and Royston-Parmar flexible parametric survival models to analyse data from Clinical Practice Research Datalink (CPRD) GOLD and Aurum databases linked with Hospital Episode Statistics (HES) and Office for National Statistics (ONS). The CPRD is a large UK primary care database, while HES contains records of patient hospitalisations within the National Health Service (NHS) in England, and ONS provides mortality data for England and Wales. These databases were used to investigate: (i) the association between type 2 diabetes and risk of incident ischaemic and non-ischaemic HF; (ii) trends in incident ischaemic and non-ischaemic HF; (iii) mortality risk following incident ischaemic and non-ischaemic HF.Results: The meta-analysis found that people with type 2 diabetes have an increased risk of incident HF compared to those without diabetes, irrespective of prevalent cardiovascular disease. The CPRD analyses found: (i) consistently higher age-standardised rates of non-ischaemic vs. ischaemic HF, greater among people with type 2 diabetes vs. without diabetes and in men vs. women; (ii) greater excess risk associated with type 2 diabetes for ischaemic HF than non-ischaemic HF, irrespective of sex; (iii) marginally declining age-standardised rates over time for ischaemic HF, but stable age-standardised rates for non-ischaemic HF, regardless of sex or diabetes status; model adjustment accounting for several comorbidities, prescription medications and demographic characteristics showed that such trends were unlikely influenced by these risk factors; (iv) lastly, age-standardised rates for all-cause mortality were similar among people with ischaemic or non-ischaemic HF, but were higher among those with type 2 diabetes compared to those without diabetes, irrespective of sex.Conclusion: This PhD thesis brings together research that provides contemporary evidence on the risk of developing HF among people with diabetes and their subsequent risk of mortality, with a particular focus on HF epidemiology based on its aetiology (ischaemic vs. non-ischaemic). These findings support the development of more tailored HF prevention, management and prognosis strategies by potentially accounting for HF aetiology and diabetes status to inform future public health and patient-level decisions.

Fields of Study & Subjects

Heart Failure Treatment and Management Cardiovascular Function and Risk Factors Diabetes Cardiovascular Risks and Lipoproteins

Publication details

Journal / source
University of Leicester
Publication date
25 March 2026
Language
EN
Document type
Thesis